We are live on
!
Find out more
SEC
Seven Eight Capital Portfolio holdings
AUM
$1.11B
1-Year Est. Return
29.48%
This Fund
S&P 500
This Quarter
Est. Return
+14.58%
1 Year Est. Return
+29.48%
3 Year Est. Return
+13.61%
5 Year Est. Return
+117.69%
10 Year Est. Return
+239.1%
AUM
$865M
AUM Growth
+$9.54M
(+1.1%)
Cap. Flow
-$78.4M
Cap. Flow
% of AUM
-9.07%
Top 10 Holdings %
Top 10 Hldgs %
8.56%
Holding
892
New
315
Increased
150
Reduced
128
Closed
299
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
XP
XP
|
+$7.27M |
| 2 |
Constellation Brands
STZ
|
+$7.01M |
| 3 |
Eli Lilly
LLY
|
+$6.9M |
| 4 |
Automatic Data Processing
ADP
|
+$6.79M |
| 5 |
Nu Holdings
NU
|
+$6.73M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Merck
MRK
|
+$11.9M |
| 2 |
Vertex Pharmaceuticals
VRTX
|
+$11.9M |
| 3 |
Microsoft
MSFT
|
+$11.8M |
| 4 |
Alphabet (Google) Class C
GOOG
|
+$11.7M |
| 5 |
Las Vegas Sands
LVS
|
+$11.2M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.67% |
| 2 | Healthcare | 18.49% |
| 3 | Consumer Discretionary | 15.79% |
| 4 | Industrials | 10.31% |
| 5 | Financials | 10.3% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
226
Spectrum Brands
SPB
$2.09B
| $1.15M | 0.13% |
+14,370
| New | +$1.08M |
|
227
UMB Financial
UMBF
$11.3B
| $1.14M | 0.13% |
+13,700
| New | +$964K |
|
228
Braze
BRZE
$2.93B
| $1.13M | 0.13% |
21,297
+15,237
| +251% | +$753K |
|
229
ManpowerGroup
MAN
$2.5B
| $1.12M | 0.13% |
14,087
+4,400
| +45% | +$327K |
|
230
Veracyte
VCYT
$3.7B
| $1.12M | 0.13% |
+40,641
| New | +$981K |
|
231
Micron Technology
MU
$1.01T
| $1.11M | 0.13% |
+12,971
| New | +$964K |
|
232
Autodesk
ADSK
$49.8B
| $1.1M | 0.13% |
+4,505
| New | +$973K |
|
233
RxSight
RXST
$258M
| $1.09M | 0.13% |
+26,918
| New | +$790K |
|
|
CTRA
234
DELISTED
Coterra Energy
CTRA
| $1.08M | 0.12% |
42,261
+22,227
| +111% | +$595K |
|
235
Ryan Specialty Holdings
RYAN
$5.66B
| $1.08M | 0.12% |
+24,992
| New | +$1.13M |
|
236
Leidos
LDOS
$16.2B
| $1.08M | 0.12% |
+9,933
| New | +$1.01M |
|
237
Manulife Financial
MFC
$74.2B
| $1.07M | 0.12% |
+48,378
| New | +$929K |
|
|
GMS
238
DELISTED
GMS Inc
GMS
| $1.07M | 0.12% |
12,970
+3,063
| +31% | +$205K |
|
239
Cheesecake Factory
CAKE
$5.24B
| $1.05M | 0.12% |
30,086
+21,007
| +231% | +$671K |
|
240
Stellantis
STLA
$21.7B
| $1.04M | 0.12% |
44,545
-69,472
| -61% | -$1.43M |
|
241
Affiliated Managers Group
AMG
$10.2B
| $1.04M | 0.12% |
+6,851
| New | +$921K |
|
242
NVR
NVR
$16.7B
| $1.04M | 0.12% |
148
-31
| -17% | -$191K |
|
243
Marqeta
MQ
$1.9B
| $1.03M | 0.12% |
36,953
+17,778
| +93% | +$426K |
|
|
MRO
244
DELISTED
Marathon Oil Corporation
MRO
| $1.03M | 0.12% |
+42,681
| New | +$1.1M |
|
245
NRG Energy
NRG
$25.5B
| $1.02M | 0.12% |
19,817
-20,507
| -51% | -$927K |
|
246
Corteva
CTVA
$51.2B
| $1.02M | 0.12% |
21,316
+3,823
| +22% | +$182K |
|
|
247
Las Vegas Sands
LVS
$30B
| $1.02M | 0.12% |
20,692
-237,981
| -92% | -$11.2M |
|
248
Owens Corning
OC
$11.7B
| $1.02M | 0.12% |
+6,867
| New | +$910K |
|
249
AMC Entertainment Holdings
AMC
$2.44B
| $1.02M | 0.12% |
+165,941
| New | +$1.35M |
|
250
Jacobs Solutions
J
$16.7B
| $1.01M | 0.12% |
+9,400
| New | +$1.02M |
|
Similar funds
PP
ECM
GCAC
CAM
D
GFS
FTIS
AIA
Seven Eight Capital's Q4 2023 Portfolio in Review
As of Q4 2023, Seven Eight Capital held 892 positions worth $865M, up 1.1% from $855M the previous quarter. Its ten largest holdings account for 8.6% of the portfolio.
Seven Eight Capital withdrew a net $78.4M in Q4 2023, closing 299 positions and reducing 128 holdings. Its most notable exit was Merck, an estimated $11.9M position sold in full.
By sector, the portfolio is most concentrated in Technology at 20% of assets, down from 20% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, Seven Eight Capital opened a new position in XP worth $8.3M.
- Seven Eight Capital's largest Q4 2023 buy was XP: 318,542 shares worth $8.3M.
- Seven Eight Capital added most to Constellation Brands in Q4 2023, an estimated $7.01M increase.
- Seven Eight Capital's biggest Q4 2023 reduction was Vertex Pharmaceuticals, cutting an estimated $11.9M.
- Seven Eight Capital fully exited Merck in Q4 2023, selling an estimated $11.9M.
- Seven Eight Capital's ten largest holdings make up 8.6% of its $865M portfolio in Q4 2023.
- Seven Eight Capital opened 315 new positions and closed 299 in Q4 2023.
- Seven Eight Capital's portfolio value rose 1.1% quarter-over-quarter to $865M.
Based on Seven Eight Capital's 13F filing for Q4 2023, filed 13 Feb 2024.